- Design
- Individual patient data meta-analysis of four randomised trials
- Population
- 1,423 patients with 1,509 non-pedunculated colorectal polyps ≥20 mm
- Primary outcome
- Major adverse events; residual or recurrent adenoma
- Effect
- Major AE 1.7% vs 5.9% (OR 0.26); residual adenoma 26.5% vs 12.8% (OR 2.61)
An individual patient data meta-analysis pooled four randomised trials of cold snare resection against hot snare endoscopic mucosal resection (EMR) for non-pedunculated colorectal polyps of 20 mm or more: 1,509 polyps (mean 31 mm) in 1,423 patients at 50 centres.
Major adverse events (deep mural injury, perforation or delayed bleeding) occurred in 1.7% after cold and 5.9% after hot resection (OR 0.26); cold snare was the only independent factor reducing them. Residual or recurrent adenoma was 26.5% against 12.8% (OR 2.61), and the difference grew with polyp size. The gap was smallest for sessile serrated lesions (15.0% against 8.1%) and largest in adenomas with high-grade dysplasia (40.8% against 18.0%).
This turns a 'which is better' debate into a selection decision. Cold resection makes sense for sessile serrated lesions and for patients at high bleeding or perforation risk, such as those on antithrombotics or with multimorbidity. For large adenomas, particularly with features suggesting high-grade dysplasia, hot EMR still gives more complete clearance.
- Assess lesion type and optical features before choosing the technique
- Favour cold snare for sessile serrated lesions of 2–4 cm
- Consider cold snare in patients on antithrombotics or with high procedural risk
- Favour hot EMR for large adenomas, especially with suspected high-grade dysplasia
- Whichever technique, arrange the 6-month scar check
Why it matters
The safer technique leaves twice as much adenoma behind, so the choice has to follow the lesion and the patient.
Don't overread it
Subgroup results come from a post hoc analysis, and the sessile serrated lesion difference did not reach significance (p = 0.053).
The statistics, in plain English
An odds ratio of 0.26 for major adverse events means about a quarter of the odds; in absolute terms about 4 fewer serious complications per 100 resections. The odds ratio of 2.61 for residual adenoma is about 14 more recurrences per 100. A significant interaction with size means the recurrence penalty of cold resection grows as polyps get larger.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for gastroenterology & hepatology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free